Japan-based Maruho Co Ltd has named Atsushi Sugita as its new president and chief executive officer, effective 18 December 2020, it was reported on Friday.
Sugita is to replace Koichi Takagi who will remain with the company as chairman of the board.
Sugita has served at Johnson & Johnson's US headquarters and Janssen Japan. He held various positions at Maruho's R&D Labs, Head Office, and global subsidiaries.
Avidity Biosciences names new Directors
Indonesia's food and drugs regulator approves China's Sinovac COVID-19 with 65.3% efficacy
Maruho names new president and CEO
BioTheryX names new president and CEO
Clerics of Indonesia's Muslim council declare Sinovac's COVID-19 vaccine halal
Silver Named to TScan Therapeutics Board of Directors
Viking Therapeutics names new CFO and COO
European Commission Authorizes COVID-19 Vaccine Moderna in Europe
McMillan Named Chief Technical Officer at SwanBio Therapeutics
Jnana Therapeutics Names Chen to Board of Directors, Susztak to Scientific Advisory Board
Entrada Therapeutics Names Kim to its Board of Directors
Nuventra Pharma Sciences names new president
Nektar Therapeutics names interim chief medical officer, head of Development